Are ketogenic diets promising for Alzheimer's disease? A translational review

被引:47
|
作者
Lilamand, Matthieu [1 ,2 ,3 ,4 ]
Porte, Baptiste [1 ,2 ]
Cognat, Emmanuel [1 ,2 ]
Hugon, Jacques [1 ,2 ]
Mouton-Liger, Francois [1 ,2 ]
Paquet, Claire [1 ,2 ]
机构
[1] Univ Paris, INSERM, U1144, Optimisat Therapeut Neuropsychopharmacol, Paris, France
[2] Nord Univ Paris, Lariboisiere Hosp, APHP, CMRR Paris Nord Ile France,Ctr Neurol Cognit, 200 Rue Faubourg, F-75010 Paris, France
[3] APHP Nord Univ Paris, Dept Geriatr, Bichat, Bretonneau Hospitals, F-75018 Paris, France
[4] Nord Univ Paris, Bichat & Bretonneau Hosp, APHP, Dept Geriatr, F-75018 Paris, France
关键词
Ketogenic diet; Alzheimer's disease; Brain metabolism; Animal models; MOUSE MODEL; COGNITIVE IMPAIRMENT; BETA-HYDROXYBUTYRATE; KETONE ESTER; SUPPLEMENTATION; METABOLISM; MITOCHONDRIA; MEMORY;
D O I
10.1186/s13195-020-00615-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Brain amyloid deposition and neurofibrillary tangles in Alzheimer's disease (AD) are associated with complex neuroinflammatory reactions such as microglial activation and cytokine production. Glucose metabolism is closely related to neuroinflammation. Ketogenic diets (KDs) include a high amount of fat, low carbohydrate and medium-chain triglyceride (MCT) intake. KDs lead to the production of ketone bodies to fuel the brain, in the absence of glucose. These nutritional interventions are validated treatments of pharmacoresistant epilepsy, consequently leading to a better intellectual development in epileptic children. In neurodegenerative diseases and cognitive decline, potential benefits of KD were previously pointed out, but the published evidence remains scarce. The main objective of this review was to critically examine the evidence regarding KD or MCT intake effects both in AD and ageing animal models and in humans. Main body We conducted a review based on a systematic search of interventional trials published from January 2000 to March 2019 found on MEDLINE and Cochrane databases. Overall, 11 animal and 11 human studies were included in the present review. In preclinical studies, this review revealed an improvement of cognition and motor function in AD mouse model and ageing animals. However, the KD and ketone supplementation were also associated with significant weight loss. In human studies, most of the published articles showed a significant improvement of cognitive outcomes (global cognition, memory and executive functions) with ketone supplementation or KD, regardless of the severity of cognitive impairments previously detected. Both interventions seemed acceptable and efficient to achieve ketosis. Conclusion The KD or MCT intake might be promising ways to alter cognitive symptoms in AD, especially at the prodromal stage of the disease. The need for efficient disease-modifying strategies suggests to pursue further KD interventional studies to assess the efficacy, the adherence to this diet and the potential adverse effects of these nutritional approaches.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Ketogenic interventions in mild cognitive impairment, Alzheimer's disease, and Parkinson's disease: A systematic review and critical appraisal
    Bohnen, Jeffrey L. B.
    Albin, Roger L.
    Bohnen, Nicolaas I.
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [22] Alzheimer's disease and other Dementias: Review of Epidemiological Data and Promising Interventions
    Arandia, Gabriela
    Reddy, P. Hemachandra
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 72 : S25 - S25
  • [23] Monoamine oxidase inhibitors: Promising therapeutic agents for Alzheimer's disease (Review)
    Cai, Zhiyou
    MOLECULAR MEDICINE REPORTS, 2014, 9 (05) : 1533 - 1541
  • [24] Biomarkers in translational research of Alzheimer's Disease
    Tarawneh, Rawan
    Holtzman, David M.
    NEUROPHARMACOLOGY, 2010, 59 (4-5) : 310 - 322
  • [25] To treat or not to treat Alzheimer's disease by the ketogenic diet? That is the question
    Ulamek-Koziol, Marzena
    Pluta, Ryszard
    NEURAL REGENERATION RESEARCH, 2020, 15 (05) : 857 - 858
  • [26] To treat or not to treat Alzheimer's disease by the ketogenic diet? That is the question
    Marzena U?amek-Kozio?
    Ryszard Pluta
    Neural Regeneration Research, 2020, (05) : 857 - 858
  • [27] High carbohydrate diets and Alzheimer's disease
    Henderson, ST
    MEDICAL HYPOTHESES, 2004, 62 (05) : 689 - 700
  • [28] Epigenetic nutraceutical diets in Alzheimer’s disease
    S. Davinelli
    V. Calabrese
    D. Zella
    Giovanni Scapagnini
    The journal of nutrition, health & aging, 2014, 18 : 800 - 805
  • [29] Epigenetic nutraceutical diets in Alzheimer's disease
    Davinelli, S.
    Calabrese, V.
    Zella, D.
    Scapagnini, G.
    JOURNAL OF NUTRITION HEALTH & AGING, 2014, 18 (09): : 800 - 805
  • [30] Flotillin: A Promising Biomarker for Alzheimer's Disease
    Angelopoulou, Efthalia
    Paudel, Yam Nath
    Shaikh, Mohd. Farooq
    Piperi, Christina
    JOURNAL OF PERSONALIZED MEDICINE, 2020, 10 (02):